Stockholders' Equity Attributable to Parent in USD of Sionna Therapeutics, Inc. from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Sionna Therapeutics, Inc. quarterly Stockholders' Equity Attributable to Parent history and change rate from Q4 2023 to Q3 2025.
  • Sionna Therapeutics, Inc. Stockholders' Equity Attributable to Parent for the quarter ending September 30, 2025 was $322M.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Sionna Therapeutics, Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $322M +$470M Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $336M +$470M Jun 30, 2025 10-Q 2025-11-05
Q1 2025 $352M +$478M Mar 31, 2025 10-Q 2025-11-05
Q4 2024 -$164M -$48.8M -42.5% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 -$149M Sep 30, 2024 10-Q 2025-11-05
Q2 2024 -$134M Jun 30, 2024 10-Q 2025-11-05
Q1 2024 -$126M Mar 31, 2024 10-Q 2025-11-05
Q4 2023 -$115M Dec 31, 2023 10-Q 2025-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.